Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02022943 · ClinicalTrials.gov registry record

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

A clinical trial of Dementia and Alzheimers Disease, sponsored by Banner Health.

Recruiting
Registry status
500,000
Enrollment target
1
Study location

NCT02022943: Recruiting study of Dementia and Alzheimers Disease, sponsored by Banner Health.

NCT02022943 is a study of Dementia and Alzheimers Disease that is actively recruiting participants, run by Banner Health. The registered enrollment target is 500,000 participants, above the 5,210-participant average among 199 other Dementia trials with a reported enrollment target (9497% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02022943, a study of Dementia and Alzheimers Disease, is actively recruiting participants, sponsored by Banner Health.

RECRUITING
Registry status
500,000 participants
Enrollment target
1
Study location

Study Summary

The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory \& thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit www.endALZnow.org

Conditions Studied

Dementia Alzheimers Disease

Study Locations (1)

Arizona

  • Banner Alzheimer's Institute - Phoenix

Trial Details

FieldValue
Enrollment Target 500,000 participants
Start Date 2012-05
Est. Completion 2030-01
Banner Health

8 total trials

What NCT02022943 shows while recruiting

NCT02022943 is an observational study that tracks outcomes without assigning an intervention. Its 500,000 participants enrollment target places it among the larger protocols in the corpus, above the 5,210-participant average among 199 other Dementia trials with a reported enrollment target (9497% higher).

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.

NCT02022943 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT02022943 about?

NCT02022943 is a clinical study titled "Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies". The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolle...

What is the current status of trial NCT02022943?

This trial is currently recruiting. The enrollment target is 500,000 participants. The study started on 2012-05. Estimated completion is 2030-01.

What conditions does trial NCT02022943 study?

This clinical trial studies the following conditions: Dementia, Alzheimers Disease.

Who is sponsoring clinical trial NCT02022943?

This trial is sponsored by Banner Health, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02022943 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02022943's enrollment target sits among peer trials

500,000 1st of 199 higher than 199 of 199 other Dementia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05065060 · 500,000 participants

    Parkinson Progression Marker Initiative Online (PPMI Online)

  • NCT06017687 · 500,000 participants · NA

    Data Collection and Evaluation of OptiBP Under Investigational Use

  • NCT06342375 · 425,000 participants · NA

    Enrollment Barriers, Procedural Denials, and Loss of Medicaid Coverage

  • NCT06934239 · 400,000 participants · Phase 4

    A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

More recruiting context for NCT02022943

Source: ClinicalTrials.gov NCT02022943, the US trial registry maintained by the National Library of Medicine. NCT02022943 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.